[1]刘夏炎,余安运,刘 益,等.血清胃蛋白酶原及相关肿瘤标志物与胃癌的相关性研究[J].现代检验医学杂志,2018,33(05):108-110+114.[doi:10.3969/j.issn.1671-7414.2018.05.029]
 LIU Xia-yan,YU An-yun,LIU Yi,et al.Relationship between Pepsinogen and Other Tumor Markers and Gastric Cancer[J].Journal of Modern Laboratory Medicine,2018,33(05):108-110+114.[doi:10.3969/j.issn.1671-7414.2018.05.029]
点击复制

血清胃蛋白酶原及相关肿瘤标志物与胃癌的相关性研究()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第33卷
期数:
2018年05期
页码:
108-110+114
栏目:
论著
出版日期:
2018-11-18

文章信息/Info

Title:
Relationship between Pepsinogen and Other Tumor Markers and Gastric Cancer
文章编号:
1671-7414(2018)05-108-04
作者:
刘夏炎余安运刘 益王 鑫张 云
陕西省康复医院检验科,西安 710065
Author(s):
LIU Xia-yanYU An-yunLIU YiWANG XinZHANG Yun
Shaanxi Kangfu Hospital,Xi'an 710065,China
关键词:
胃蛋白酶原 糖类抗原 癌胚抗原 胃癌
分类号:
R735.2; R730.43
DOI:
10.3969/j.issn.1671-7414.2018.05.029
文献标志码:
A
摘要:
目的 探讨胃蛋白酶原(PGⅠ,PGⅡ)及相关肿瘤标志物与胃癌的相关性。方法 采用全自动生化分析仪,罗氏电化学发光仪检测胃癌组患者(192例)、胃炎组患者(135例)及健康对照组人群(164例)血清中PGⅠ,PGⅡ,糖类抗原(CA-724,CA-199)和癌胚抗原(CEA)水平,计算PGⅠ/PGⅡ(Ⅰ/Ⅱ)值,分析上述指标与胃癌的相关性。结果 ①胃癌组、胃炎组和健康对照组间PGⅠ,PGⅡ,Ⅰ/Ⅱ,CA-724,CA-199和CEA差异均有统计学意义(F=27.56,36.54,27.87,19.78,16.89,19.01,均P<0.05); ②胃癌组中转移组PGⅠ,Ⅰ/Ⅱ,CA-199水平高于未转移组,差异有统计学意义(t=29.36,6.79,6.33,均P<0.05); ③I/II与胃癌TNM分期呈负相关(r=-0.513,P=0.007 1),CA-724,CA-199与胃癌TNM分期呈正相关(r=0.452,0.427,P=0.008 2,0.042); ④六种血清肿瘤标记物在胃癌中的敏感度、特异度和准确度不同,其中以Ⅰ/Ⅱ敏感度(68.38%)、特异度(97.10%)、准确度(65.39%)较高。结论 Ⅰ/Ⅱ,CA-724,CA19-9与胃癌具有较强的相关性,并且敏感度、特异度较高; 在胃癌转移监测中PGⅠ/PGⅡ比值,CA-199更具有临床价值。
Abstract:
Objective Objectived to explore the relationship between pepsinogen(PGⅠ,PGⅡ)and other tumor markers and gastric cancer.Methods The PGⅠ,PGⅡ,CA-724,CA-199 and CEA levels inserum of patients with the gastric cancer group(192 cases),the gastritis group(135 cases)and the healthy control group(164 cases)were detected by automatic biochemical analyzer and Roche electrochemical luminescence method.CalculatedPGⅠ/PGⅡ(Ⅰ/Ⅱ)value and analysed their relationship with gastric cancer.Results ①There were significant differences in PGⅠ,PGⅡ,Ⅰ/Ⅱ,CA-724,CA-199 and CEA between the three groups in the gastric cancer group,the gastritis group and the healthy control group(F=27.56,36.54,27.87,19.78,16.89,19.01,all P<0.05).②The levels of PGⅠ,Ⅰ/Ⅱ and CA-199 in the gastric cancer group were higher than those in the non metastasis group(t=29.36,6.79,6.33,all P<0.05).③Ⅰ/Ⅱ was negatively correlated with TNM staging of gastric cancer(r=-0.513,P=0.007 1)and CA-724,CA-199 was positively correlated with TNM staging of gastric cancer(r=0.452,0.427,P=0.008 2,0.042).④The sensitivity,specificity and accuracy of six serum tumor markers in gastric cancer were different.Among them,Ⅰ/Ⅱ sensitivity(68.38%),specificity(97.10%),accuracy(65.39%)was highest.Conclusion Ⅰ/Ⅱ,CA-724 and CA19-9 had strong correlation with gastric cancer,and the sensitivity and specificity were high.In the monitoring of metastasis of gastric cancer,PGⅠ,PGⅠ/PGⅡ and CA-199 had more clinical value.

参考文献/References:

[1] Jemal A,Center MM,DeSantis C,et al.Global patterns of cancerincidence and mortality rates and trends[J].Cancer Epidemiol Biomarkers Prey,2010,19(8):1893-1907.
[2] 韦志鹃,张晓云.血清胃功能检测在早期胃癌筛查中的临床应用研究[J].国际检验医学杂志,2017,38(16):2240-2242.
Wei ZJ,Zhang XY.Clinical application of serum gastric function detection in early gastric cancer screening[J].International Journal of Laboratory Medicine,2017,38(16):2240-2242.
[3] 吕艳丽,李 毅,刘光顺,等.胃癌高发区血清胃蛋白酶原初筛加高危人群胃镜检查方案与直接胃镜筛查方案的效果比较[J].中华肿瘤杂志,2013,35(5):394-397.
L(¨overu)YL,Li Y,Liu GS,et al.Comparison of two gastric cancer screening schemes in a high-risk population[J].Chinese Journal of Oncology,2013,35(5):394-397.
[4] 李月红,张祥宏,黄 飚,等.胃癌高发区居民血清胃蛋白酶原水平及异常标准的研究[J].中华流行病学杂志,2006,27(10):840-844.
Li YH,Zhang XH,Huang B,et al.Studies on the cut-off value of serum pepsinogen abnormality for screening chronic atrophic gastritis and gastriccarcinoma[J].Chin J Epidemiol,2006,27(10):840-844.
[5] 刘春兴.上海地区胃蛋白酶原参考值的建立及临床应用[J].现代检验医学杂志,2015,30(1):121-123,125.
Liu CX.Establishment of pepsinogen reference range and its clinicalapplication in Shanghai area[J].J Mod Lab Med,2015,30(1):121-123,125.
[6] Lukaszewicz-Zaj Ac M,Mroczko B,Gryko M,et al.Comparison between clinical significance of serum proinflammatory proteins(IL-6 and CRP)and classic tumor markers(CEA and CA 19-9)in gastric cancer[J].Clinical & Experimental Medicine,2011,11(2):89-96.
[7] 廉 伟,赵 缜,赵 芳,等.三种方法检测胃蛋白酶原I的比较及临床应用[J].现代检验医学杂志,2014,29(1):132-135.
Lian W,Zhao Z,Zhao F,et al.Detection of pepsinogen I by three different methods and its clinical application[J].J Mod Lab Med,2014,29(1):132-135.
[8] Correa P.Serum pepsinogens in gastric cancer screening[J].Dig Dis Sci,2010,55(8):2123-2125.

相似文献/References:

[1]段秀枝,金苑卿.健康人群血清PG定量检测和Hp感染的临床意义[J].现代检验医学杂志,2016,31(02):26.[doi:10.3969/j.issn.1671-7414.2016.02.008]
 DUAN Xiu-zhi,JIN Yuan-qing.Clinical Meaning of Pepsinogen Test and Helicobacter Pylori Serology in the Health Check-up Population[J].Journal of Modern Laboratory Medicine,2016,31(05):26.[doi:10.3969/j.issn.1671-7414.2016.02.008]
[2]房国忠,吴 红,杨 琛.联合检测血清胃蛋白酶原和胸苷激酶1在胃部疾病诊断中的意义[J].现代检验医学杂志,2016,31(02):124.[doi:10.3969/j.issn.1671-7414.2016.02.037]
 FANG Guo-zhong,WU Hong,YANG Chen.Clinical Significance of Detecting Serum Pepsinogen and Thymidine Kinase 1 Levels in Patients with Gastric Diseases[J].Journal of Modern Laboratory Medicine,2016,31(05):124.[doi:10.3969/j.issn.1671-7414.2016.02.037]
[3]杨建华,王炳华,林 勇.血清胃蛋白酶原和胃泌素-17 对萎缩性胃炎及胃癌患者诊断价值[J].现代检验医学杂志,2016,31(03):51.[doi:10.3969/j.issn.1671-7414.2016.03.014]
 YANG Jian-hua,WANG Bing-hua,LIN Yong.Clinical Value of Serum Pepsinogen and Gastrin-17 Levels in Patients with Atrophic Gastritis and Gastric Cancer[J].Journal of Modern Laboratory Medicine,2016,31(05):51.[doi:10.3969/j.issn.1671-7414.2016.03.014]
[4]胡 娟,徐 鹏,呼永河,等.不同海拔高度人群胃蛋白酶原血清水平差异性分析[J].现代检验医学杂志,2015,30(03):32.[doi:10.3969/j.issn.1671-7414.2015.03.009]
 HU Juan,XU Peng,HU Yong-he,et al.Analysis on Variations of Serum Pepsinogen in Different Altitude Population[J].Journal of Modern Laboratory Medicine,2015,30(05):32.[doi:10.3969/j.issn.1671-7414.2015.03.009]
[5]周 勃.天津铁路健康体检员工血清胃蛋白酶原水平调查研究[J].现代检验医学杂志,2020,35(03):138.[doi:10.3969/j.issn.1671-7414.2020.03.037]
 ZHOU Bo.Investigation and Study on Serum Pepsinogen Levels in Physical Examination Staff of Tianjin Railway[J].Journal of Modern Laboratory Medicine,2020,35(05):138.[doi:10.3969/j.issn.1671-7414.2020.03.037]

备注/Memo

备注/Memo:
作者简介:刘夏炎(1979-),女,本科,主管检验师,检验科副主任,主要从事生化及临床实验诊断学研究,E-mail:674172600@qq.com。
更新日期/Last Update: 2018-09-30